Raphael Pharmaceutical Inc.
SEC CIK 1415397 · RAPH · last insider filing 2026-04-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Louria Hayon Igal | Director · Chief Technology Officer | filed 2022 - 2026 |
| Laor Zvi Laufer | Director | filed 2025 - 2025 |
| Eliya Yehuda | Director · Chief Financial Officer | filed 2022 - 2025 |
| Pilo Shlomo | Director · Chief Executive Officer | filed 2022 - 2025 |
| Dhadha Ajay Kumar | Director | filed 2025 - 2025 |
| Ofir Guy | Director · President and Director | filed 2008 - 2023 |
| Press Joseph | Director | filed 2022 - 2023 |
| Catell Robert B | Director | filed 2010 - 2010 |
| Yanay Elisha | Director | filed 2010 - 2010 |
| Shamash Yacov A | Director | filed 2010 - 2010 |
| Cohen Emanuel | Director · Secretary Treasurer Director | filed 2008 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.